Eosinophilic Fasciitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-11-20
Clinical Trial Update: Mepolizumab for Eosinophilic Fasciitis [Phase 1]
A Phase 1 clinical trial evaluating mepolizumab for eosinophilic fasciitis has been withdrawn.